☰

Rick A. Bright, Ph.D. - Publications

Affiliations: 
2002 Emory University, Atlanta, GA 
 2010- Biomedical Advanced Research Development Authority (BARDA) 
Area:
Immunology, Molecular Biology
Tree Info Similar researchers PubMed Report error

34/45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M, Chavan S, Do R, Lin C, Oke I, Rhodes KE, Santhosh A, Sandhu AT, Chu S, Patel SA, ... ... Bright RA, et al. Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries. Vaccine. PMID 34836659 DOI: 10.1016/j.vaccine.2021.11.016  0.475
2021 Oshansky CM, King J, Lu D, Zhou J, Pavetto C, Horwith G, Biscardi K, Nguyen B, Treanor JJ, Chen LM, Jepson B, Bright RA, Johnson RA, Cioce V, et al. Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults. Npj Vaccines. 6: 41. PMID 33741987 DOI: 10.1038/s41541-021-00287-7  0.64
2019 King JC, Beigel JH, Ison MG, Rothman RE, Uyeki TM, Walker RE, Neaton JD, Tegeris JS, Zhou JA, Armstrong KL, Carter W, Miele PS, Willis MS, Dugas AF, Tracy LA, ... ... Bright RA, et al. Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations. Open Forum Infectious Diseases. 6: ofz137. PMID 31037242 DOI: 10.1093/Ofid/Ofz137  0.536
2018 Oshansky CM, Zhou J, Gao Y, Schweinle JE, Biscardi K, DeBeauchamp J, Pavetto C, Wollish A, Webby RJ, Cioce V, Donis RO, Bright RA. Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS). Vaccine. PMID 30553570 DOI: 10.1016/J.Vaccine.2018.11.069  0.583
2013 Gessner BD, Brooks WA, Neuzil KM, Vernet G, Bright RA, Tam JS, Bresee J, Monto AS. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). Vaccine. 31: 3222-8. PMID 23707161 DOI: 10.1016/J.Vaccine.2013.05.017  0.591
2013 Wathen MW, Barro M, Bright RA. Antivirals in seasonal and pandemic influenza--future perspectives. Influenza and Other Respiratory Viruses. 7: 76-80. PMID 23279900 DOI: 10.1111/Irv.12049  0.579
2012 Neuzil KM, Tsvetnitsky V, Nyari LJ, Bright RA, Boslego JW. PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries. Expert Review of Vaccines. 11: 939-47. PMID 23002975 DOI: 10.1586/Erv.12.76  0.645
2011 Perdue ML, Bright RA. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world. Vaccine. 29: A48-50. PMID 21684430 DOI: 10.1016/J.Vaccine.2011.02.080  0.558
2010 Mochalova L, Bright R, Xu X, Korchagina E, Chinarev A, Bovin N, Klimov A. Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors. Glycoconjugate Journal. 27: 321-7. PMID 20195900 DOI: 10.1007/S10719-010-9280-7  0.557
2009 Bright RA, Neuzil KM, Pervikov Y, Palkonyay L. WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008. Vaccine. 27: 6366-9. PMID 19840675 DOI: 10.1016/J.Vaccine.2009.02.084  0.581
2009 Kang SM, Pushko P, Bright RA, Smith G, Compans RW. Influenza virus-like particles as pandemic vaccines. Current Topics in Microbiology and Immunology. 333: 269-89. PMID 19768411 DOI: 10.1007/978-3-540-92165-3_14  0.666
2009 Neuzil KM, Bright RA. Influenza vaccine manufacture: keeping up with change. The Journal of Infectious Diseases. 200: 835-7. PMID 19673653 DOI: 10.1086/605507  0.628
2009 Ross TM, Mahmood K, Crevar CJ, Schneider-Ohrum K, Heaton PM, Bright RA. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. Plos One. 4: e6032. PMID 19554101 DOI: 10.1371/Journal.Pone.0006032  0.682
2009 Deyde VM, Nguyen T, Bright RA, Balish A, Shu B, Lindstrom S, Klimov AI, Gubareva LV. Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrobial Agents and Chemotherapy. 53: 1039-47. PMID 19124660 DOI: 10.1128/Aac.01446-08  0.572
2008 Maines TR, Szretter KJ, Perrone L, Belser JA, Bright RA, Zeng H, Tumpey TM, Katz JM. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunological Reviews. 225: 68-84. PMID 18837776 DOI: 10.1111/J.1600-065X.2008.00690.X  0.665
2008 Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine. 26: 5393-9. PMID 18706956 DOI: 10.1016/J.Vaccine.2008.07.084  0.63
2008 Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrobial Agents and Chemotherapy. 52: 3284-92. PMID 18625765 DOI: 10.1128/Aac.00555-08  0.636
2008 Rahman M, Bright RA, Kieke BA, Donahue JG, Greenlee RT, Vandermause M, Balish A, Foust A, Cox NJ, Klimov AI, Shay DK, Belongia EA. Adamantane-resistant influenza infection during the 2004-05 season. Emerging Infectious Diseases. 14: 173-6. PMID 18258102 DOI: 10.3201/Eid1401.070460  0.564
2008 Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. Plos One. 3: e1501. PMID 18231588 DOI: 10.1371/Journal.Pone.0001501  0.68
2007 Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. The Journal of Infectious Diseases. 196: 249-57. PMID 17570112 DOI: 10.1086/518936  0.618
2007 Chen H, Bright RA, Subbarao K, Smith C, Cox NJ, Katz JM, Matsuoka Y. Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. Virus Research. 128: 159-63. PMID 17521765 DOI: 10.1016/J.Virusres.2007.04.017  0.707
2007 Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, Smith G, Wright DC, Bright RA. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine. 25: 4283-90. PMID 17403562 DOI: 10.1016/j.vaccine.2007.02.059  0.755
2007 Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine. 25: 3871-8. PMID 17337102 DOI: 10.1016/J.Vaccine.2007.01.106  0.656
2006 Hoelscher MA, Garg S, Bangari DS, Belser JA, Lu X, Stephenson I, Bright RA, Katz JM, Mittal SK, Sambhara S. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet (London, England). 367: 475-81. PMID 16473124 DOI: 10.1016/S0140-6736(06)68076-8  0.75
2006 Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. Jama. 295: 891-4. PMID 16456087 DOI: 10.1001/Jama.295.8.Joc60020  0.631
2006 Shay DK, Bright RA, Shaw M, Cox NJ, Klimov AI. Shift Shown in Influenza A Adamantane Resistance—Reply Jama. 296: 1585. DOI: 10.1001/Jama.296.13.1586  0.688
2005 Aubin JT, Azebi S, Balish A, Banks J, Bhat N, Bright RA, Brown I, Buchy P, Burguiere AM, Chen HI, Cheng P, Cox NJ, Crosier A, Curns A, Cuvelier F, et al. Evolution of H5N1 avian influenza viruses in Asia Emerging Infectious Diseases. 11: 1515-1521. PMID 16318689  0.699
2005 Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet (London, England). 366: 1175-81. PMID 16198766 DOI: 10.1016/S0140-6736(05)67338-2  0.659
2005 Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Johnson CM, Olsen CW, Cox NJ, et al. Transmission of equine influenza virus to dogs. Science (New York, N.Y.). 310: 482-5. PMID 16186182 DOI: 10.1126/Science.1117950  0.749
2003 Bright RA, Cho DS, Rowe T, Katz JM. Mechanisms of pathogenicity of influenza A (H5N1) viruses in mice. Avian Diseases. 47: 1131-4. PMID 14575128 DOI: 10.1637/0005-2086-47.S3.1131  0.741
2003 Rowe T, Cho DS, Bright RA, Zitzow LA, Katz JM. Neurological manifestations of avian influenza viruses in mammals. Avian Diseases. 47: 1122-6. PMID 14575126 DOI: 10.1637/0005-2086-47.S3.1122  0.656
2003 Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM. Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology. 308: 270-8. PMID 12706077 DOI: 10.1016/S0042-6822(03)00008-4  0.72
2003 Mitchell JA, Green TD, Bright RA, Ross TM. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine. 21: 902-14. PMID 12547601 DOI: 10.1016/S0264-410X(02)00539-X  0.692
2000 Ross TM, Xu Y, Bright RA, Robinson HL. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge Nature Immunology. 1: 127-131. PMID 11248804 DOI: 10.1038/77802  0.474
Low-probability matches (unlikely to be authored by this person)
2022 Borio LL, Bright RA, Emanuel EJ. A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics. Jama. 327: 215-216. PMID 34989782 DOI: 10.1001/jama.2021.24165  0.255
2016 Arabi YM, Fowler R, Bright RA, Van Kerkhove MD, Balkhy HH. Knowledge gaps in therapeutic and non-therapeutic research on the Middle East respiratory syndrome. The Lancet. Respiratory Medicine. 4: 93-4. PMID 26868624 DOI: 10.1016/S2213-2600(16)00007-2  0.223
2022 Walsh TJ, Bright RA, Ahuja A, McCarthy MW, Marfuggi RA, Simpson SQ. Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms. Open Forum Infectious Diseases. 10: ofac645. PMID 36686626 DOI: 10.1093/ofid/ofac645  0.18
2022 Emanuel EJ, Michaels D, Bright RA. Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply. Jama. 327: 1825. PMID 35536267 DOI: 10.1001/jama.2022.4302  0.086
2022 Michaels D, Emanuel EJ, Bright RA. A National Strategy for COVID-19: Testing, Surveillance, and Mitigation Strategies. Jama. 327: 213-214. PMID 34989785 DOI: 10.1001/jama.2021.24168  0.085
2023 Ongarello S, Bausch DG, Hannay E, Bright RA. Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats. The Lancet. Global Health. 11: e1340. PMID 37591580 DOI: 10.1016/S2214-109X(23)00306-6  0.063
2020 Tromberg BJ, Schwetz TA, Pérez-Stable EJ, Hodes RJ, Woychik RP, Bright RA, Fleurence RL, Collins FS. Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States - The NIH RADx Initiative. The New England Journal of Medicine. PMID 32706958 DOI: 10.1056/Nejmsr2022263  0.054
2020 Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M, Chavan S, Oke I, Pennini ME, Santhosh A, Wax M, Woodbury R, Chu S, Merkeley TG, Disbrow GL, ... Bright RA, et al. Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012-2018. Critical Care Medicine. 48: 276-288. PMID 32058366 DOI: 10.1097/Ccm.0000000000004224  0.049
2020 Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M, Chavan S, Oke I, Pennini ME, Santhosh A, Wax M, Woodbury R, Chu S, Merkeley TG, Disbrow GL, ... Bright RA, et al. Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012-2018. Critical Care Medicine. 48: 289-301. PMID 32058367 DOI: 10.1097/Ccm.0000000000004226  0.043
2020 Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M, Chavan S, Oke I, Pennini ME, Santhosh A, Wax M, Woodbury R, Chu S, Merkeley TG, Disbrow GL, ... Bright RA, et al. Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012-2018. Critical Care Medicine. 48: 302-318. PMID 32058368 DOI: 10.1097/Ccm.0000000000004225  0.042
2023 Dzau V, Swaminathan S, Baker C, Bright RA, Castillo J, Chuan TC, Draghia-Akli R, Eardley-Patel R, Gao GF, Ishii K, Tebeje YK, Lambe T, Machingaidze S, Røttingen JA, Shaligram U, et al. The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation. Lancet (London, England). PMID 37683681 DOI: 10.1016/S0140-6736(23)01775-0  0.015
Hide low-probability matches.